ÀÏÀß·¯Ã¤¿ë°ü
ä¿ëÁ¤º¸
ÀÎÀç°Ë»ö
±³À°Á¤º¸
ÇìµåÇåÆÃ
½º¸¶Æ®Å¸¿î
ȸ¿ø¼­ºñ½º
À̷¼­ µî·Ï
ä¿ë°ø°í µî·Ï

Oncology Key Account Manager (Stivarga / Xofigo)

¾÷Á¾ ÀÇ·á/Á¦¾à/°Ç°­ ÀÚº»±Ý
±â¾÷ÇüÅ ¿Ü±¹±â¾÷ ¸ÅÃâÇöȲ
´ëÇ¥ÀÚ »ç¿ø¼ö
ȸ»çÁÖ¼Ò ¼­¿ï Ưº°½Ã µ¿ÀÛ±¸ º¸¶ó¸Å·Î 5±æ 23 (½Å´ë¹æµ¿ 395-62) »ï¼ºº¸¶ó¸Å ¿È´ÏŸ¿ö
  • ÇöÀç ä¿ëÁ¤º¸¸¦ º¹»çÇÕ´Ï´Ù.
  • ÇöÀç ä¿ëÁ¤º¸¸¦ ÇÁ¸°ÆÃÇÕ´Ï´Ù.




Á÷Á¾ º¸°Ç¡¤ÀÇ·á
±Ù¹«ÇüÅ Á¤±ÔÁ÷ ä¿ëÁ÷±Þ -
¸ðÁýÀοø 0 ¸í ³ªÀÌ Á¦ÇѾøÀ½
°æ·Â °æ·Â ±Þ¿©Á¶°Ç ´ç»ç±ÔÁ¤
Çз ´ëÁ¹ ÀÌ»ó Á¢¼ö±â°£ Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù
 [ȨÆäÀÌÁöÁ¢¼ö]

Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù

* ´ã´ç¾÷¹«
»ó¼¼Á¶°Ç



¡Ü
¸ðÁýºÎ¼­


  ¡Û Specialty Medicine BU in PH

  ¡Û BHC




¡Ü
¾÷¹«°³¿ä


  ¡Û Understand and capture the stakeholder/thought leaders landscape and account specific needs including the

     decision map of each KA

  ¡Û
Define and develop strategic KA plans consistently within the framework of BHP¡®s brand plans

  ¡Û
Drive close collaboration with marketing, brand optimizing team, medical and other functions to add value, develop

     and implement tailor made marketing mix based on confirmed KA needs

  ¡Û
Ensure that all latest brand related scientific information is delivered to the Medical Thought Leaders as well as the

     referring departments/physicians

  ¡Û
Responsible for continuous overview of the ¡®input/output relation¡¯ of the KA

  ¡Û
Forecast demand regularly and set up yearly sales plan for each KA

   -
Comply with all relevant pharmaceutical regulations(especially Code of Conduct)and BHC ethical business

     practices




¡Ü
ÀÀ½ÃÀÚ°Ý


   ¡Û
University degree

   ¡Û
More than 5 years'' sales/related experience

   ¡Û
Intelligence on the oncology products and market

   ¡Û
Good knowledge or learning ability to understand products and therapeutic areas.

   ¡Û Good interpersonal skill and communication skills

   ¡Û Possess a high level of business ethics, integrity and professionalism




¡Ü
Á¢¼ö±â°£ ¹× Á¢¼ö¹æ¹ý


   ¡Û Á¢¼ö±â°£

      - 2014³â 03¿ù 17ÀÏ (¿ù) ~ 2014³â 03¿ù 31ÀÏ (¿ù) ±îÁö

   ¡Û Á¢¼ö¹æ¹ý

      - ´ç»ç ȨÆäÀÌÁö Á¢¼ö ÀÌ¿ë





* ÀÔ»çÁö¿ø ½Ã Áß¿ä»çÇ×À» ²À üũÇϼ¼¿ä!

* ±Ù¹«È¯°æ
±Ù¹«Áö¿ª : ¼­¿ï
±Þ¿©Á¶°Ç : ´ç»ç±ÔÁ¤
* Á¢¼ö°³¿ä

¿À´Ã¸¶°¨

Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù

¡á Á¢¼ö±â°£   ¡á ¿À´Ã   ¡á ¸¶°¨

2014. 03

  • ÀÏ
  • ¿ù
  • È­
  • ¼ö
  • ¸ñ
  • ±Ý
  • Åä
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
* ´ã´çÀÚ Á¤º¸
¸ðÁý±â°£ÀÌ Áö³­ ä¿ëÁ¤º¸ÀÇ °æ¿ì ´ã´çÁ¤º¸´Â °ø°³µÇÁö ¾Ê½À´Ï´Ù.
ÇöÀç ä¿ëÁ¤º¸¸¦ º¹»çÇÕ´Ï´Ù. ÇöÀç ä¿ëÁ¤º¸¸¦ ÇÁ¸°ÆÃÇÕ´Ï´Ù.

µî·Ï : 2014³â 3¿ù 17ÀÏ (¿ù) 16:06    ÃÖÁ¾¼öÁ¤ : 2014³â 3¿ù 17ÀÏ (¿ù) 16:06

º» Á¤º¸´Â ¹ÙÀÌ¿¤ÄÚ¸®¾Æ ¿¡¼­ Á¦°øÇÑ ÀÚ·áÀ̸ç, ½ºÄ«¿ìÆ®Àº(´Â) ±× ³»¿ë»óÀÇ ¿À·ù ¹× Áö¿¬, ±× ³»¿ëÀ» ½Å·ÚÇÏ¿© ÃëÇØÁø Á¶Ä¡¿¡ ´ëÇÏ¿© Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. º» Á¤º¸´Â ½ºÄ«¿ìÆ®ÀÇ µ¿ÀÇ ¾øÀÌ Àç¹èÆ÷ÇÒ ¼ö ¾ø½À´Ï´Ù.

¢À ½ºÄ«¿ìÆ® ¿¡¼­´Â °ÅÁþ ±¸ÀÎ ±¤°í¿¡ ´ëÇÑ ÇÇÇØ¸¦ ÃÖ¼ÒÈ­ Çϱâ À§ÇÏ¿© ÇãÀ§ ä¿ë°ø°í¿¡ ½Å°íÁ¦µµ¸¦ ½ÃÇàÇϰí ÀÖ½À´Ï´Ù.
°ÅÁþ±¸Àα¤°í¿¡ ´ëÇÑ ±¸Á÷ÀÚÁÖÀÇ»çÇ× ½Å°íÆ÷»ó±ÝÁ¦ ¾È³» ÇãÀ§ ä¿ë°ø°í ½Å°íÇϱâ

±Ù¹«Áö À§Ä¡ º¸±â

±Ù¹«Áö ÁÖ¼Ò

¼­¿ï Ưº°½Ã µ¿ÀÛ±¸ º¸¶ó¸Å·Î 5±æ 23 (½Å´ë¹æµ¿ 395-62) »ï¼ºº¸¶ó¸Å ¿È´ÏŸ¿ö

Å©°Ôº¸±â

[ƯÁý±âȹ] ¹ý·ü»ç¹«Á÷

Á÷¾÷µ¸º¸±â

¹ý·ü»ç¹«Á÷À̶õ?º¯..

¸éÁ¢ helper

¸éÁ¢Áú¹®

Àμº ¡Ú¡Ú¡Ú¡Ú
Àû¼º ¡Ú¡Ú¡Ú¡Ú

Special Interview

½ºÆä¼ÈÀÎÅͺä
¹ý·ü »ç¹«Á÷À̶ó´Â ÀÏÀÌ ¾î¶² ÀÏÀÎÁö Àß ¸ð..

À¯»çÁ÷Á¾ÀÇ Ã¤¿ë Á¤º¸